Insiders · MBII

Stuart Woolf

Director at Marrone Bio Innovations Inc (MBII)

Stuart Woolf has filed 8 insider reports with the SEC since April 2021, as director at Marrone Bio Innovations Inc (MBII). The latest filing, on July 15, 2022, reports grant or award, sale back to the company and exercise or conversion of a derivative at Marrone Bio Innovations Inc (MBII).

Filings
8
Companies
1
Bought on market
None
Sold on market
None

Companies where Stuart Woolf is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Marrone Bio Innovations Inc logo
MBII
Marrone Bio Innovations Inc
Director0Jul 15, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Stuart Woolf with

Questions about Stuart Woolf

What is Stuart Woolf's role at Marrone Bio Innovations Inc?
Stuart Woolf reports to the SEC as director at Marrone Bio Innovations Inc (MBII), according to the latest filing on July 15, 2022.
Has Stuart Woolf bought or sold stock recently?
No open-market purchases or sales by Stuart Woolf are on file. The filings report grant or award, sale back to the company and exercise or conversion of a derivative.
How do I get alerts when Stuart Woolf files?
Follow Stuart Woolf on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Stuart Woolf (SEC CIK 0001748858). Totals count each trade once, skipping amendments whose original is on file, from Apr 2, 2021 on. View on SEC EDGAR